XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated other comprehensive income/(loss)
Deferred compensation
Deficit accumulated during development stage
Comprehensive loss
Balance at Aug. 12, 1996                
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses $ 1     $ 1        
Comprehensive loss:                
Translation adjustment (4)       (4)     (4)
Loss for the year (290)           (290) (290)
Comprehensive loss for the year (294)             (294)
Balances at Mar. 31, 1997 (293)     1 (4)   (290)  
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 4,217     4,217        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     266,778          
Issue of shares for IP rights agreement, research & development agreement and license agreement 262     262        
Stock-based compensation       2,002   (2,002)    
Amortization of deferred stock-based compensation 302         302    
Comprehensive loss:                
Translation adjustment 55       55     55
Loss for the year (2,534)           (2,534) (2,534)
Comprehensive loss for the year (2,479)             (2,479)
Balances at Mar. 31, 1998 2,009     6,482 51 (1,700) (2,824)  
Balances (in shares) at Mar. 31, 1998     266,778          
Increase (Decrease) in Stockholders' Equity                
Amortization of deferred stock-based compensation 406         406    
Comprehensive loss:                
Translation adjustment 11       11     11
Loss for the year (3,964)           (3,964) (3,964)
Comprehensive loss for the year (3,953)             (3,953)
Balances at Mar. 31, 1999 (1,538)     6,482 62 (1,294) (6,788)  
Balance (in shares) at Mar. 31, 1999     266,778          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 12,717   1 12,716        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     538,889          
Issue of shares on conversion of bridging loan and Loan Note Instrument 1,638     1,638        
Issue of shares on conversion of bridging loan and Loan Note Instrument (in shares)     90,602          
Issue of shares in lieu of cash bonus 164     164        
Issue of shares in lieu of cash bonus (in shares)     9,060          
Issue of shares for IP rights agreement, research & development agreement and license agreement 409     409        
Issue of common stock upon exercise of stock options 40     40        
Issue of common stock upon exercise of stock options (in shares)     2,265          
Stock-based compensation       167   (167)    
Amortization of deferred stock-based compensation 433         433    
Comprehensive loss:                
Translation adjustment (194)       (194)     (194)
Loss for the year (5,686)           (5,686) (5,686)
Comprehensive loss for the year (5,880)             (5,880)
Balances at Mar. 31, 2000 7,983   1 21,616 (132) (1,028) (12,474)  
Balances (in shares) at Mar. 31, 2000     907,594          
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation       294   (294)    
Amortization of deferred stock-based compensation 275         275    
Comprehensive loss:                
Translation adjustment (466)       (466)     (466)
Loss for the year (10,382)           (10,382) (10,382)
Comprehensive loss for the year (10,848)             (10,848)
Balances at Mar. 31, 2001 (2,590)   1 21,910 (598) (1,047) (22,856)  
Balance (in shares) at Mar. 31, 2001     907,594          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses     0          
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     5,451          
Issue of warrants in connection with registered direct offering 1,215     1,215        
Issue of shares for IP rights agreement, research & development agreement and license agreement 183     183        
Issue of shares for IP rights agreement, research & development agreement and license agreement (in shares)     4,510          
Issue of common stock upon exercise of stock options 106     106        
Stock-based compensation       363   (363)    
Amortization of deferred stock-based compensation 672         672    
Comprehensive loss:                
Translation adjustment 191       191     191
Loss for the year (14,853)           (14,853) (14,853)
Comprehensive loss for the year (14,662)             (14,662)
Balances at Mar. 31, 2002 (15,076)   1 23,777 (407) (738) (37,709)  
Balances (in shares) at Mar. 31, 2002     917,555          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock upon exercise of stock options 12     12        
Stock-based compensation       (84)   84    
Amortization of deferred stock-based compensation 305         305    
Comprehensive loss:                
Translation adjustment (1,846)       (1,846)     (1,846)
Loss for the year (15,542)           (15,542) (15,542)
Comprehensive loss for the year (17,388)             (17,388)
Balances at Mar. 31, 2003 (32,147)   1 23,705 (2,253) (349) (53,251)  
Balance (in shares) at Mar. 31, 2003     917,555          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 27,635   1 27,634        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     1,510,288          
Preferred stock conversions 58,148   4 58,144        
Preferred stock conversions (in shares)     3,769,139          
Issue of common stock upon exercise of stock options 115     115        
Issue of common stock upon exercise of stock options (in shares)     6,549          
Amortization of deferred stock-based compensation 217         217    
Comprehensive loss:                
Translation adjustment (1,343)       (1,343)     (1,343)
Loss for the year (14,977)           (14,977) (14,977)
Comprehensive loss for the year (16,320)             (16,320)
Balances at Dec. 31, 2003 37,648   6 109,598 (3,596) (132) (68,228)  
Balances (in shares) at Dec. 31, 2003     6,203,531          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 8,541   1 8,540        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     430,571          
Warrant exercise (in shares)     22,630          
Stock-based compensation (1,918)     (2,050)   132    
Comprehensive loss:                
Translation adjustment 2,424       2,424     2,424
Loss for the year (22,742)           (22,742) (22,742)
Comprehensive loss for the year (20,318)             (20,318)
Balances at Dec. 31, 2004 23,953   7 116,088 (1,172)   (90,970)  
Balances (in shares) at Dec. 31, 2004     6,656,732          
Comprehensive loss:                
Translation adjustment (1,786)       (1,786)     (1,786)
Loss for the year (18,048)           (18,048) (18,048)
Comprehensive loss for the year (19,834)             (19,834)
Balances at Dec. 31, 2005 4,119   7 116,088 (2,958)   (109,018)  
Balance (in shares) at Dec. 31, 2005     6,656,732          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock     1 (1)        
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock (in shares)     648,413          
Issue of shares on conversion of bridging loan and Loan Note Instrument (in shares)     456,308          
Reverse Acquisition 16,255 2 2 16,251        
Reverse Acquisition (in shares)   2,046,813 1,967,928          
Loan from Cyclacel Group plc waived 10,420     10,420        
Issue of common stock and warrants for cash 42,362   6 42,356        
Issue of common stock and warrants for cash (in shares)     6,428,572          
Stock-based compensation 9,600     9,600        
Change in unrealized loss on investment 5       5      
Comprehensive loss:                
Translation adjustment 416       416     416
Loss for the year (29,258)           (29,258) (29,258)
Comprehensive loss for the year (28,842)             (28,842)
Balances at Dec. 31, 2006 53,919 2 16 194,714 (2,537)   (138,276)  
Balances (in shares) at Dec. 31, 2006   2,046,813 16,157,953          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 33,357   4 33,353        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     4,249,668          
Issue of warrants in connection with registered direct offering (6,750)     (6,750)        
Issue of common stock upon exercise of stock options 163     163        
Issue of common stock upon exercise of stock options (in shares)     25,508          
Stock-based compensation 1,733     1,733        
Preferred stock dividends (307)     (307)        
Comprehensive loss:                
Translation adjustment (93)       (93)     (93)
Loss for the year (24,053)           (24,053) (24,053)
Comprehensive loss for the year (24,146)             (24,146)
Balances at Dec. 31, 2007 57,969 2 20 222,906 (2,630)   (162,329)  
Balances (in shares) at Dec. 31, 2007   2,046,813 20,433,129          
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation 1,698     1,698        
Preferred stock dividends (1,227)     (1,227)        
Comprehensive loss:                
Unrealized foreign exchange on intercompany loans (12,330)       (12,330)     (12,330)
Translation adjustment 14,918       14,918     14,918
Loss for the year (40,386)           (40,386) (40,386)
Comprehensive loss for the year (37,798)             (37,798)
Balances at Dec. 31, 2008 20,642 2 20 223,377 (42)   (202,715)  
Balances (in shares) at Dec. 31, 2008   2,046,813 20,433,129          
Increase (Decrease) in Stockholders' Equity                
Warrant re-pricing 44     44        
Issue of common stock for cash on registered direct offering, net of expenses 2,847   4 2,843        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     4,000,000          
Issue of common stock upon draw down of Committed Equity Finance Facility 1,030   2 1,028        
Issue of common stock upon draw down of Committed Equity Finance Facility (in shares)     1,255,024          
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock 7     7        
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock (in shares)     55,210          
Stock-based compensation 810     810        
Comprehensive loss:                
Unrealized foreign exchange on intercompany loans 5,651       5,651     5,651
Translation adjustment (5,589)       (5,589)     (5,589)
Loss for the year (19,570)           (19,570) (19,570)
Comprehensive loss for the year (19,508)             (19,508)
Balances at Dec. 31, 2009 5,872 2 26 228,109 20   (222,285)  
Balances (in shares) at Dec. 31, 2009   2,046,813 25,743,363          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 11,897   5 11,892        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     5,200,000          
Issue of common stock upon draw down of Committed Equity Finance Facility 4,863   3 4,860        
Issue of common stock upon draw down of Committed Equity Finance Facility (in shares)     2,818,925          
Warrant exercise 2,499   3 2,496        
Warrant exercise (in shares)     2,618,266          
Issue of common stock on private placement, net of expenses 13,980   8 13,972        
Issue of common stock on private placement, net of expenses (in shares)     8,323,190          
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock 77     77        
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock (in shares)     205,571          
Preferred stock conversions   (1) 2 3,514     (3,515)  
Preferred stock conversions (in shares)   (833,671) 1,655,599          
Stock-based compensation 1,746     1,746        
Comprehensive loss:                
Unrealized foreign exchange on intercompany loans (2,073)       (2,073)     (2,073)
Translation adjustment 2,084       2,084     2,084
Loss for the year (16,021)           (16,021) (16,021)
Comprehensive loss for the year (16,010)             (16,010)
Balances at Dec. 31, 2010 24,924 1 47 266,666 31   (241,821)  
Balances (in shares) at Dec. 31, 2010   1,213,142 46,564,914          
Increase (Decrease) in Stockholders' Equity                
Issue of common stock for cash on registered direct offering, net of expenses 9,272   7 9,265        
Issue of common stock for cash on registered direct offering, net of expenses (in shares)     7,617,646          
Issue of common stock upon draw down of Committed Equity Finance Facility       0        
Warrant exercise     0          
Issue of common stock on private placement, net of expenses     0          
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock 3     3        
Issue of common stock to certain directors and officers upon exercise of stock options, stock-based awards exercised, restricted stock units and restricted stock (in shares)     37,898          
Preferred stock conversions     0          
Stock-based compensation 882     882        
Preferred stock dividends (364)     (364)        
Comprehensive loss:                
Unrealized foreign exchange on intercompany loans (622)       (622)     (622)
Translation adjustment 648       648     648
Loss for the year (15,243)           (15,243) (15,243)
Comprehensive loss for the year (15,217)             (15,217)
Balances at Dec. 31, 2011 $ 19,500 $ 1 $ 54 $ 276,452 $ 57   $ (257,064)  
Balances (in shares) at Dec. 31, 2011   1,213,142 54,220,458